S. 41Senate115th Congress (2017-2019)In Committee

Medicare Prescription Drug Price Negotiation Act of 2017

Introduced January 5, 2017

AI-Generated Summary

Updated April 15, 2026 at 11:14 AM UTC

The Medicare Prescription Drug Price Negotiation Act of 2017 would require the Secretary of Health and Human Services to negotiate lower prices for covered Part D drugs on behalf of Medicare beneficiaries. The negotiations apply to drugs covered under prescription drug plans and Medicare Advantage prescription drug (MA‑PD) plans. The rule does not change how formularies are set, but allows plan sponsors to obtain discounts below the negotiated price. The Secretary must report the negotiations and resulting discounts to Congress twice each year.

Key Provisions

  • Amends Section 1860D-11 of the Social Security Act to give the HHS Secretary authority to negotiate prices, discounts, rebates, and other concessions for covered Part D drugs.
  • Specifies that the Secretary cannot dictate formulary composition, and plan sponsors may still secure lower prices than the negotiated amount.
  • Requires the Secretary to submit semi‑annual reports to designated House and Senate committees detailing negotiation activities and achieved price reductions.
  • Effective immediately upon enactment, applying to plan years beginning on January 1, 2018.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Finance.

January 5, 2017

View full timeline
SenateIntro Referral

Introduced in Senate

January 5, 2017

SenateIntro Referral

Read twice and referred to the Committee on Finance.

January 5, 2017

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued January 5, 2017

II

115th CONGRESS

1st Session

S. 41

IN THE SENATE OF THE UNITED STATES

January 5, 2017

Ms. Klobuchar (for herself, Mr. Blumenthal, Mrs. Shaheen, Ms. Baldwin, Mr. King, Mr. Brown, Mr. Leahy, Mr. Franken, and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate covered part D drug prices on behalf of Medicare beneficiaries.

1.

Short title

This Act may be cited as the Medicare Prescription Drug Price Negotiation Act of 2017.

2.

Negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries

(a)

Negotiation by Secretary

Section 1860D–11 of the Social Security Act (42 U.S.C. 1395w–111) is amended by striking subsection (i) (relating to noninterference) and inserting the following:

(i)

Negotiation of Lower Drug Prices

(1)

In general

Notwithstanding any other provision of law, the Secretary shall negotiate with pharmaceutical manufacturers the prices (including discounts, rebates, and other price concessions) that may be charged to PDP sponsors and MA organizations for covered part D drugs for part D eligible individuals who are enrolled under a prescription drug plan or under an MA–PD plan.

(2)

No change in rules for formularies

(A)

In general

Nothing in paragraph (1) shall be construed to authorize the Secretary to establish or require a particular formulary.

(B)

Construction

Subparagraph (A) shall not be construed as affecting the Secretary’s authority to ensure appropriate and adequate access to covered part D drugs under prescription drug plans and under MA–PD plans, including compliance of such plans with formulary requirements under section 1860D–4(b)(3).

(3)

Construction

Nothing in this subsection shall be construed as preventing the sponsor of a prescription drug plan, or an organization offering an MA–PD plan, from obtaining a discount or reduction of the price for a covered part D drug below the price negotiated under paragraph (1).

(4)

Semi-annual reports to congress

Not later than June 1, 2018, and every 6 months thereafter, the Secretary shall submit to the Committees on Ways and Means, Energy and Commerce, and Oversight and Government Reform of the House of Representatives and the Committee on Finance of the Senate a report on negotiations conducted by the Secretary to achieve lower prices for Medicare beneficiaries, and the prices and price discounts achieved by the Secretary as a result of such negotiations.

.

(b)

Effective date

The amendment made by subsection (a) shall take effect on the date of the enactment of this Act and shall first apply to negotiations and prices for plan years beginning on January 1, 2018.